Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link
Dow Jones Industrial Average
) is trading up 81 points (+0.5%) at 15,918 as of Tuesday, Jan 28, 2014, 9:35 a.m. ET. During this time, 16.8 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 362.1 million. The NYSE advances/declines ratio sits at 1,858 issues advancing vs. 861 declining with 217 unchanged.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The Dow component leading the way higher looks to be
), which is sporting a 63-cent gain (+2.1%) bringing the stock to $30.29. This single gain is lifting the Dow Jones Industrial Average by 4.77 points or roughly accounting for 5.9% of the Dow's overall gain. Volume for Pfizer currently sits at 1.8 million shares traded vs. an average daily trading volume of 24.3 million shares.
Pfizer has a market cap of $195.02 billion and is part of the health care sector and drugs industry. Shares are down 3.2% year to date as of Monday's close. The stock's dividend yield sits at 3.5%.
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. The company has a P/E ratio of 19.9, above the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Pfizer as a
. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations, increase in stock price during the past year and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income.
- You can view the full Pfizer Ratings Report.
Holding back the Dow today is
), which is lagging the broader Dow index with a 44-cent decline (-0.6%) bringing the stock to $78.50. Volume for Home Depot currently sits at 532,429 shares traded vs. an average daily trading volume of 6.4 million shares.
Home Depot has a market cap of $111.48 billion and is part of the services sector and retail industry. Shares are down 4.1% year to date as of Monday's close. The stock's dividend yield sits at 2%.
The Home Depot, Inc. operates as a home improvement retailer. The company has a P/E ratio of 21.4, above the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Home Depot as a
. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, notable return on equity and good cash flow from operations. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated.
- You can view the full Home Depot Ratings Report.